Your browser doesn't support javascript.
loading
Comparison of Cost and Perioperative Outcomes Among Patients Undergoing Simple Prostatectomy and Laser Enucleation of the Prostate.
Hawken, Scott R; French, William; Kay, Hannah; Scales, Charles D; Viprakasit, Davis P; Friedlander, David F.
Affiliation
  • Hawken SR; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • French W; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Kay H; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Scales CD; Department of Urology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Viprakasit DP; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Friedlander DF; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
J Endourol ; 37(1): 60-66, 2023 01.
Article in En | MEDLINE | ID: mdl-36193580
ABSTRACT

Introduction:

Simple prostatectomy (SP) and laser enucleation of the prostate (LEP) are treatments for symptomatic benign prostatic hyperplasia (BPH) in men with large glands (e.g., >80 g). The decision between the two operations is often dependent on surgeon preference/experience and equipment availability. As the use of minimally invasive techniques, such as robotic-assisted simple prostatectomy, has increased for the treatment of large gland BPH, studies comparing the outcomes and cost of these modalities in a contemporary cohort are lacking.

Methods:

All-payer data from Healthcare Cost and Utilization Project State Databases from Florida, New York, California, and Maryland from 2016 to 2018 were used to identify adults who underwent SP or LEP for BPH. Patient demographics, facility characteristics, revisit rates, and cost of the index hospitalization were examined. Multivariable logistic and gamma generalized linear regression models were utilized to compare predictors of the operation performed, 30-day revisits, and index hospitalization cost among the two operations.

Results:

Of the 2032 patients in the cohort, 1067 (46.4%) underwent LEP and 965 (41.9%) underwent SP. On multivariable logistic regression analysis, SP patients were younger, had higher comorbidity scores, and were more likely to be uninsured compared with LEP patients. Thirty-day revisit rates among the operations were equivalent (odds ratio 0.89, 95% confidence interval 0.63-1.27, p = 0.05). The mean adjusted cost of the index hospital stay for LEP was significantly greater than that of SP ($7291 vs $6442, p = 0.04). However, our sub-group analysis examining high-volume centers revealed no significant differences in cost ($6184 vs $5353, p = 0.1).

Conclusions:

Across the four states examined, SP and LEP were performed with comparable volume and had similar rates of 30-day revisits. The SP was less expensive than LEP overall; however, among high-volume facilities, the cost of both operations was reduced, such that they were equivalent.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Laser Therapy Type of study: Health_economic_evaluation / Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: J Endourol Journal subject: UROLOGIA Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Laser Therapy Type of study: Health_economic_evaluation / Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: J Endourol Journal subject: UROLOGIA Year: 2023 Document type: Article Affiliation country: